德源药业
(920735)
| 流通市值：29.01亿 | | | 总市值：32.80亿 |
| 流通股本：1.14亿 | | | 总股本：1.29亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 134,324,711.52 | 148,270,963.44 | 109,231,224.94 | 79,253,208.95 |
| 交易性金融资产 | 370,765,534.25 | 340,993,419.9 | 360,720,457.53 | 358,663,012.07 |
| 应收票据及应收账款 | 316,914,083.72 | 279,376,520.3 | 242,672,303.94 | 266,890,511.19 |
| 其中：应收票据 | 96,804,583.97 | 77,987,934.95 | 68,603,480.69 | 87,554,947.64 |
| 应收账款 | 220,109,499.75 | 201,388,585.35 | 174,068,823.25 | 179,335,563.55 |
| 预付款项 | 1,346,490.09 | 1,561,032.41 | 1,245,826.19 | 605,185.53 |
| 其他应收款合计 | 303,427.61 | 309,500.54 | 167,733.28 | 231,963.5 |
| 存货 | 104,609,975.88 | 89,589,220.4 | 81,501,976.36 | 78,117,177.12 |
| 一年内到期的非流动资产 | 52,531,390.8 | 75,072,559.18 | 63,687,479.91 | 52,734,886.3 |
| 其他流动资产 | 68,832.6 | 158,106.59 | 257,469.93 | - |
| 流动资产合计 | 980,864,446.47 | 935,331,322.76 | 859,484,472.08 | 836,495,944.66 |
| 非流动资产: | | | | |
| 长期股权投资 | 8,426,296.12 | 8,513,634.11 | 8,607,297.35 | 9,061,247.37 |
| 其他权益工具投资 | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 |
| 固定资产 | 434,845,152.77 | 438,572,337.46 | 442,993,967.61 | 142,907,396.45 |
| 在建工程 | 113,711,074.98 | 81,014,097.17 | 69,381,206.26 | 346,096,503.69 |
| 使用权资产 | 2,681,900.2 | 3,041,654.88 | 1,272,822.27 | 1,473,794.21 |
| 无形资产 | 47,988,468.65 | 48,369,692.03 | 48,750,915.41 | 49,132,138.79 |
| 长期待摊费用 | 226,587.67 | 289,227.85 | 351,868.03 | 414,508.21 |
| 递延所得税资产 | 13,049,576.97 | 13,191,374.97 | 12,091,783.37 | 12,335,054.5 |
| 其他非流动资产 | 104,802,037.67 | 121,078,913.91 | 124,159,331.06 | 128,617,837.15 |
| 非流动资产合计 | 729,731,095.03 | 718,070,932.38 | 711,609,191.36 | 694,038,480.37 |
| 资产总计 | 1,710,595,541.5 | 1,653,402,255.14 | 1,571,093,663.44 | 1,530,534,425.03 |
| 流动负债: | | | | |
| 短期借款 | 13,049,162.57 | 9,041,487.62 | 8,796,215.61 | - |
| 应付票据及应付账款 | 147,374,490.54 | 129,265,211.66 | 110,756,008.48 | 129,401,934.63 |
| 其中：应付票据 | 64,775,550 | 52,998,651.19 | 44,236,686.91 | 45,536,644.03 |
| 应付账款 | 82,598,940.54 | 76,266,560.47 | 66,519,321.57 | 83,865,290.6 |
| 合同负债 | 1,355,789.11 | 2,160,143.42 | 2,362,555.2 | 3,013,169.95 |
| 应付职工薪酬 | 24,929,091.3 | 20,975,438.77 | 26,375,253.19 | 34,338,384.25 |
| 应交税费 | 31,764,647.19 | 25,361,397.25 | 19,669,591.31 | 37,668,843.82 |
| 其他应付款合计 | 24,263,591.61 | 70,691,979.5 | 23,208,273.02 | 23,079,938.27 |
| 应付股利 | - | 46,926,396 | - | - |
| 一年内到期的非流动负债 | 1,512,981.22 | 1,501,645.57 | 813,572.32 | 807,827.82 |
| 其他流动负债 | 176,252.58 | 280,818.64 | 287,728.17 | 391,712.09 |
| 流动负债合计 | 244,426,006.12 | 259,278,122.43 | 192,269,197.3 | 228,701,810.83 |
| 非流动负债: | | | | |
| 租赁负债 | 788,131.69 | 785,086.87 | - | - |
| 递延收益 | 76,757,797.74 | 77,861,161.44 | 71,933,688.14 | 72,944,540.84 |
| 非流动负债合计 | 77,545,929.43 | 78,646,248.31 | 71,933,688.14 | 72,944,540.84 |
| 负债合计 | 321,971,935.55 | 337,924,370.74 | 264,202,885.44 | 301,646,351.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 129,047,589 | 117,315,990 | 117,315,990 | 117,315,990 |
| 资本公积 | 350,832,260.15 | 362,563,859.15 | 362,563,859.15 | 362,563,859.15 |
| 盈余公积 | 58,657,995 | 58,657,995 | 58,657,995 | 42,279,526.38 |
| 未分配利润 | 850,085,761.8 | 776,940,040.25 | 768,352,933.85 | 706,728,697.83 |
| 归属于母公司股东权益合计 | 1,388,623,605.95 | 1,315,477,884.4 | 1,306,890,778 | 1,228,888,073.36 |
| 股东权益合计 | 1,388,623,605.95 | 1,315,477,884.4 | 1,306,890,778 | 1,228,888,073.36 |
| 负债和股东权益合计 | 1,710,595,541.5 | 1,653,402,255.14 | 1,571,093,663.44 | 1,530,534,425.03 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-03-05 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |